ArticleScientific reports2025
Amoxicillin conjugated functionalized zinc ferrite nanoparticles for enhanced antibacterial, antibiofilm, and antioxidant activities.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Grafted magnetite FeScientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To address the growing challenge of antibiotic resistance, magnetic nanoparticles were developed and characterized by providing an innovative solution. Zinc ferrite nanoparticles (ZnFe₂O₄ NPs) were synthesized using a chemical co-precipitation method, stabilized with citric acid (CA), and conjugated with amoxicillin (AX) to create ZnF-CA-AX nanocomposites. These nanoparticles were extensively characterized by their structural and optical properties. The antimicrobial activity of the nanocomposites was tested against gram-positive Staphylococcus aureus and gram-negative Escherichia coli, showing significant inhibition zones. Furthermore, the nanocomposites showed a high level of antibiofilm efficiency, and potential antioxidant activity against 1,1-diphenyl-2-picrylhydrazyl. Collectively, these findings indicate that magnetic nanoparticles can enhance antibiotic effectiveness, offering new therapeutic avenues to combat resistant bacterial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.